Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer

Table 1

Association of RUNX2 expression with clinicopathological features of epithelial ovarian cancer tissues.

Features	No. of patients	RUNX2 expression (n, %)		P
		Low	High
Age
<50	48	16 (33.3)	32 (66.7)	0.69
≥50	68	22 (32.4)	46 (67.6)
Clinial stage
I~II	26	18 (69.2)	8 (30.8)	0.001
III~IV	90	20 (22.2)	70 (77.8)
Pathological grade
1~2	33	15 (45.5)	18 (54.5)	0.06
3	83	23 (27.7)	60 (72.3)
Histological type
Serous	88	28 (31.2)	60 (68.8)	0.57
Non-serous	28	10 (35.7)	18 (64.3)
Residual tumor after surgery
<1 cm	66	23 (34.8)	43 (65.2)	0.51
≥1 cm	50	15 (30.0)	35 (70.0)